Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Premier Perspective on Biomarkers in Oncology By Premier Research November 2, 2022 Clinical ResearchPhase 1 - Phase 4 Antibody-Drug Conjugates in Oncology: Key Considerations and Future Trends By Premier Research October 13, 2022 Clinical ResearchPhase 1 - Phase 4 Leveraging Real-World Data & Real-World Evidence to Support Regulatory Decision Making By Nach Davé October 3, 2022 Clinical ResearchPhase 1 - Phase 4 A Fit-for-Purpose Path Forward: Linking RWD to Your Overall Data Strategy By Nach Davé September 26, 2022 Clinical ResearchPhase 1 - Phase 4 What is Real-World Data and Evidence and How It Can Facilitate Clinical Development By Nach Davé September 19, 2022 Clinical ResearchPhase 1 - Phase 4 How to Select Drugs to Switch from Rx to OTC By Colleen Coleman September 12, 2022 Previous 1 …7 8 9 10 11 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today